Principal Financial Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,572
Closed -$391K 2260
2024
Q2
$391K Sell
10,572
-2,581
-20% -$97.4K ﹤0.01% 2010
2024
Q1
$552K Buy
13,153
+1,194
+10% +$49K ﹤0.01% 1966
2023
Q4
$474K Sell
11,959
-889
-7% -$26.1K ﹤0.01% 1964
2023
Q3
$354K Buy
12,848
+1,497
+13% +$46.9K ﹤0.01% 2017
2023
Q2
$385K Sell
11,351
-696
-6% -$23.5K ﹤0.01% 2010
2023
Q1
$433K Buy
12,047
+1,394
+13% +$60.2K ﹤0.01% 2000
2022
Q4
$475K Buy
10,653
+108
+1% +$3.86K ﹤0.01% 1990
2022
Q3
$297K Buy
10,545
+1,907
+22% +$58.5K ﹤0.01% 2083
2022
Q2
$233K Sell
8,638
-33,851
-80% -$983K ﹤0.01% 2256
2022
Q1
$1.45M Sell
42,489
-15,114
-26% -$483K ﹤0.01% 1914
2021
Q4
$2.23M Sell
57,603
-35,825
-38% -$1.56M ﹤0.01% 1840
2021
Q3
$5.04M Buy
93,428
+9,563
+11% +$449K ﹤0.01% 1680
2021
Q2
$2.8M Buy
+83,865
New +$2.3M ﹤0.01% 1838
2018
Q4
Sell
-1,377
Closed -$9K 2252
2018
Q3
$9K Buy
1,377
+46
+3% +$322 ﹤0.01% 2288
2018
Q2
$10K Sell
1,331
-1,345
-50% -$18K ﹤0.01% 2270
2018
Q1
$93K Buy
2,676
+215
+9% +$8.33K ﹤0.01% 2159
2017
Q4
$105K Buy
2,461
+1,399
+132% +$59.9K ﹤0.01% 2183
2017
Q3
$46K Sell
1,062
-210
-17% -$7.87K ﹤0.01% 2185
2017
Q2
$47K Buy
1,272
+317
+33% +$14K ﹤0.01% 2235
2017
Q1
$52K Sell
955
-136
-12% -$7.08K ﹤0.01% 2178
2016
Q4
$58K Hold
1,091
﹤0.01% 2193
2016
Q3
$66K Hold
1,091
﹤0.01% 2128
2016
Q2
$72K Sell
1,091
-58
-5% -$3.68K ﹤0.01% 2114
2016
Q1
$65K Buy
1,149
+14
+1% +$1.57K ﹤0.01% 2111
2015
Q4
$267K Buy
1,135
+22
+2% +$4.8K ﹤0.01% 1975
2015
Q3
$176K Buy
1,113
+214
+24% +$60.6K ﹤0.01% 2048
2015
Q2
$340K Buy
899
+38
+4% +$15.1K ﹤0.01% 1930
2015
Q1
$360K Sell
861
-11
-1% -$3.94K ﹤0.01% 1881
2014
Q4
$239K Sell
872
-118
-12% -$29.3K ﹤0.01% 1995
2014
Q3
$192K Hold
990
﹤0.01% 2036
2014
Q2
$242K Sell
990
-763
-44% -$172K ﹤0.01% 2025
2014
Q1
$465K Sell
1,753
-3
-0.2% -$1.15K ﹤0.01% 1879
2013
Q4
$638K Sell
1,756
-2
-0.1% -$770 ﹤0.01% 1839
2013
Q3
$934K Buy
1,758
+101
+6% +$34.6K ﹤0.01% 1756
2013
Q2
$388K Buy
+1,657
New +$326K ﹤0.01% 1879

Other funds holding CLDX